Business · 09/09/2009

FDA Releases Draft Guidance for In Vitro Diagnostic Devices for Human Papillomavirus Detection

The Food and Drug Administration (FDA) has made available a draft guidance document outlining its recommendations for analytical and clinical performance studies to support premarket submissions for in vitro diagnostic devices intended for human papillomavirus detection or differentiation.